Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramyocardial Stem Cell Application with Transmyocardial Laser Revascularisation in CABG Patients
2005-004051-35Phase 2Completed
- Sponsor
- Universitätsklinikum Düsseldorf
- Start
- Jan 2006
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of Autologous Mesenchymal Stem Cells in Chronic Coronary Syndrome (CCS), sponsored by Universitätsklinikum Düsseldorf. Primary endpoint: Evaluation of safety. Started Jan 2006; status: completed.
02
Drugs
Autologous Mesenchymal Stem Cells
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on 2005-004051-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004051-35.